Skip to main content
Fig. 2 | Trials

Fig. 2

From: A Study of Individualized Diagnosis and Treatment for Depression with Atypical Features (iDoT-AFD): study protocol for a randomized clinical trial and prognosis study

Fig. 2

Participant timeline

MCCB, MATRICS Consensus Cognitive Battery; MRI, magnetic resonance imaging; MINI, M.I.N.I International Neuropsychiatric Interview; HAMD, Hamilton’s Depression Scale with 24 items; QIDS, Quick Inventory of Depressive Symptomatology (self-report) with 16 items; HAMA, Hamilton’s Anxiety Scale; HCL, Hypomania Symptom Checklist-32; QOL, Quality of Life Scale with 6 items; AER, adverse events report; SSRI/SNRI, selective serotonin reuptake inhibitor/serotonin-noradrenaline reuptake inhibitor; TAU, treatment as usual

Back to article page

Trials

ISSN: 1745-6215